Exane Derivatives Cidara Therapeutics, Inc. Transaction History

Exane Derivatives

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$2.06 - $3.01 $96,249 - $140,636	-46,723 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$1.99 - $3.25 $21,605 - $35,285	10,857 Added 30.27%	46,723 $93,000
Q3 2020 Oct 06, 2020	SELL	$2.85 - $4.1 $6,694 - $9,630	-2,349 Reduced 6.15%	35,866 $102,000
Q1 2020 Apr 17, 2020	BUY	$1.74 - $4.26 $66,494 - $162,795	38,215 New	38,215 $94,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.